Works by Nikcevich, Daniel

Results: 16

Phase II NCCTG trial of RT + irinotecan and adjuvant BCNU plus irinotecan for newly diagnosed GBM.

Published in:

Journal of Neuro-Oncology, 2010, v. 99, n. 1, p. 73, doi. 10.1007/s11060-009-0103-2

By:

Jaeckle, Kurt A.;
Ballman, Karla V.;
Giannini, Caterina;
Schomberg, Paula J.;
Ames, Matthew M.;
Reid, Joel M.;
McGovern, Renee M.;
Safgren, Stephanie L.;
Galanis, Evanthia;
Uhm, Joon H.;
Brown, Paul D.;
Hammack, Julie E.;
Arusell, Robert;
Nikcevich, Daniel A.;
Morton, Roscoe F.;
Wender, Donald B.;
Buckner, Jan C.

Publication type:

Article

Phase II trial of two different irinotecan schedules with pharmacokinetic analysis in patients with recurrent glioma: North Central Cancer Treatment Group results.

Published in:

Journal of Neuro-Oncology, 2009, v. 92, n. 2, p. 165

By:

Jan Buckner;
Joel Reid;
Wenting Wu;
Bernd Scheithauer;
Matthew Ames;
Sara Felten;
Daniel Nikcevich;
Martin Wiesenfeld;
Kurt Jaeckle;
Evanthia Galanis

Publication type:

Article

The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9.

Published in:

Supportive Care in Cancer, 2013, v. 21, n. 4, p. 1185, doi. 10.1007/s00520-012-1647-9

By:

Barton, Debra;
Burger, Kelli;
Novotny, Paul;
Fitch, Tom;
Kohli, Sadhna;
Soori, Gamini;
Wilwerding, Mary;
Sloan, Jeff;
Kottschade, Lisa;
Rowland, Kendrith;
Dakhil, Shaker;
Nikcevich, Daniel;
Loprinzi, Charles

Publication type:

Article

Does Sunscreen Prevent Epidermal Growth Factor Receptor (EGFR) Inhibitor-Induced Rash? Results of a Placebo-Controlled Trial from the North Central Cancer Treatment Group (N05C4).

Published in:

Oncologist, 2010, v. 15, n. 9, p. 1016, doi. 10.1634/theoncologist.2010-0082

By:

JATOI, AMINAH;
THROWER, ABBY;
SLOAN, JEFF A.;
FLYNN, PATRICK J.;
WENTWORTH-HARTUNG, NICOLE LEA;
DAKHIL, SHAKER R.;
MATTAR, BASSAM I.;
NIKCEVICH, DANIEL A.;
NOVOTNY, PAUL;
SEKULIC, ALEKSANDAR;
LOPRINZI, CHARLES L.

Publication type:

Article

Long-term follow-up of chemoimmunotherapy with rituximab, oxaliplatin, cytosine arabinoside, dexamethasone (ROAD) in patients with relapsed CD20+ B-cell non-Hodgkin lymphoma: Results of a study of the Mayo Clinic Cancer Center Research Consortium (MCCRC) MC0485 now known as academic and community cancer research united (ACCRU)

Published in:

American Journal of Hematology, 2017, v. 92, n. 10, p. 1004, doi. 10.1002/ajh.24824

By:

Witzig, Thomas E.;
Johnston, Patrick B.;
LaPlant, Betsy R.;
Kurtin, Paul J.;
Pederson, Levi D.;
Moore Jr, Dennis F.;
Nabbout, Nassim H.;
Nikcevich, Daniel A.;
Rowland, Kendrith M.;
Grothey, Axel

Publication type:

Article

Akt inhibitor MK-2206 in combination with bendamustine and rituximab in relapsed or refractory chronic lymphocytic leukemia: Results from the N1087 alliance study.

Published in:

American Journal of Hematology, 2017, v. 92, n. 8, p. 759, doi. 10.1002/ajh.24762

By:

Larsen, Jeremy T.;
Shanafelt, Tait D.;
Leis, Jose F.;
LaPlant, Betsy;
Call, Tim;
Pettinger, Adam;
Hanson, Curtis;
Erlichman, Charles;
Habermann, Thomas Matthew;
Reeder, Craig;
Nikcevich, Daniel;
Bowen, Deborah;
Conte, Michael;
Boysen, Justin;
Secreto, Charla;
Lesnick, Connie;
Tschumper, Renee;
Jelinek, Diane;
Kay, Neil E.;
Ding, Wei

Publication type:

Article

A randomized comparison of once weekly epoetin alfa to extended schedule epoetin or darbepoetin in chemotherapy-associated anemia.

Published in:

American Journal of Hematology, 2015, v. 90, n. 10, p. 877, doi. 10.1002/ajh.24110

By:

Steensma, David P.;
Dakhil, Shaker R.;
Novotny, Paul J.;
Sloan, Jeff A.;
Johnson, David B.;
Anderson, Daniel M.;
Mattar, Bassam I.;
Moore, Dennis F.;
Nikcevich, Daniel;
Loprinzi, Charles L.

Publication type:

Article

A Phase II NCCTG study of irinotecan and docetaxel in previously treated patients with non-small cell lung cancer.

Published in:

2006

By:

Molina, Julian R.;
Nikcevich, Daniel;
Hillman, Shauna;
Geyer, Susan;
Drevyanko, Timothy;
Jett, James;
Verdirame, Joseph;
Tazelaar, Henry;
Rowland, Kendrith;
Wos, Edward;
Kutteh, Leila;
Nair, Suresh;
Fitch, Tom;
Flynn, Patrick;
Stella, Philip;
Adjei, Alex A.

Publication type:

journal article

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma : a North Central Cancer Treatment Group Study, N057E(1).

Published in:

2011

By:

Kottschade LA;
Suman VJ;
Amatruda T 3rd;
McWilliams RR;
Mattar BI;
Nikcevich DA;
Behrens R;
Fitch TR;
Jaslowski AJ;
Markovic SN;
Kottschade, Lisa A;
Suman, Vera J;
Amatruda, Thomas 3rd;
McWilliams, Robert R;
Mattar, Bassam I;
Nikcevich, Daniel A;
Behrens, Robert;
Fitch, Tom R;
Jaslowski, Anthony J;
Markovic, Svetomir N

Publication type:

journal article

A phase II trial of nab-paclitaxel (ABI-007) and carboplatin in patients with unresectable stage IV melanoma.

Published in:

Cancer (0008543X), 2011, v. 117, n. 8, p. 1704, doi. 10.1002/cncr.25659

By:

Kottschade, Lisa A.;
Suman, Vera J.;
Amatruda III, Thomas;
McWilliams, Robert R.;
Mattar, Bassam I.;
Nikcevich, Daniel A.;
Behrens, Robert;
Fitch, Tom R.;
Jaslowski, Anthony J.;
Markovic, Svetomir N.

Publication type:

Article

Phase 2 trial of pemetrexed disodium and carboplatin in previously untreated extensive-stage small cell lung cancer, N0423.

Published in:

2010

By:

Chee CE;
Jett JR;
Bernath AM Jr;
Foster NR;
Nelson GD;
Molina J;
Nikcevich DA;
Steen PD;
Flynn PJ;
Rowland KM Jr;
Chee, Cheng E;
Jett, James R;
Bernath, Albert M Jr;
Foster, Nathan R;
Nelson, Garth D;
Molina, Julian;
Nikcevich, Daniel A;
Steen, Preston D;
Flynn, Patrick J;
Rowland, Kendrith M Jr

Publication type:

journal article

Phase 2 Trial of Pemetrexed Disodium and Carboplatin in Previously Untreated Extensive – Stage Small Cell Lung Cancer, N0423.

Published in:

Cancer (0008543X), 2010, v. 116, n. 10, p. 2382, doi. 10.1002/cncr.24967

By:

Cheng E. Chee;
Jett, James P.;
Bernath, Albert M.;
Foster, Nathan R.;
Nelson, Garth D.;
Molina, Julian;
Nikcevich, Daniel A.;
Steen, Preston D.;
Flynn, Patrick J.;
Rowland, Jr, Kendrith M.

Publication type:

Article

A Phase 2 Study of Gemcitabine and Epirubicin for the Treatment of Pleural Mesothelioma.

Published in:

Cancer (0008543X), 2008, v. 112, n. 8, p. 1772, doi. 10.1002/cncr.23313

By:

Okuno, Scott H.;
Delaune, Robert;
Sloan, Jeff A.;
Foster, Nathan R.;
Maurer, Matthew J.;
Aubry, Marie-Christine;
Rowland Jr., Kendrith M.;
Soori, Gamini S.;
Nikcevich, Daniel A.;
Kardinal, Carl G.;
Northfelt, Donald W.;
Adjei, Alex A.

Publication type:

Article

Efficacy of Gabapentin in the Management of Chemotherapy-induced Peripheral Neuropathy.

Published in:

Cancer (0008543X), 2007, v. 110, n. 9, p. 2110, doi. 10.1002/cncr.23008

By:

Rao, Ravi D.;
Michalak, John C.;
Sloan, Jeff A.;
Loprinzi, Charles L.;
Soori, Gamini S.;
Nikcevich, Daniel A.;
Warner, David;
Novotny, Paul;
Kutteh, Leila A.;
Wong, Gilbert Y.

Publication type:

Article

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Published in:

Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 537, doi. 10.1007/s10549-018-4713-2

By:

Wagner, Lynne I.;
Zhao, Fengmin;
Goss, Paul E.;
Chapman, Judith-Anne W.;
Shepherd, Lois E.;
Whelan, Timothy J.;
Mattar, Bassam I.;
Bufill, Jose A.;
Schultz, William C.;
LaFrancis, Irving E.;
Nagargoje, Gauri G.;
Vemuri, Radhakrishna;
Nikcevich, Daniel A.;
Sledge, George W.;
Cella, David

Publication type:

Article

Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC.

Published in:

Breast Cancer Research & Treatment, 2009, v. 117, n. 3, p. 603, doi. 10.1007/s10549-009-0332-2

By:

Hines, Stephanie;
Mincey, Betty;
Dentchev, Todor;
Sloan, Jeff;
Perez, Edith;
Johnson, David;
Schaefer, Paul;
Alberts, Steve;
Liu, Heshan;
Kahanic, Stephen;
Mazurczak, Miroslaw;
Nikcevich, Daniel;
Loprinzi, Charles

Publication type:

Article